Skip to main content
Clinical Trials/CTRI/2024/01/062060
CTRI/2024/01/062060
Not yet recruiting
Phase 4

A Randomized clinical study to evaluate the efficacy of sirvyadha with or without jatamayadi lepa in vata - rakta w.s.r to gout - NI

Dr Sambu Surendran0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Sambu Surendran
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Sambu Surendran

Eligibility Criteria

Inclusion Criteria

  • a.Subject with hyperuricemia and presenting with lakshanas of Vatarakta.
  • b.Chronicity less than 5 years,
  • c.Not associated with complete joint destruction.
  • d.Uric acid above 7 mg/dl

Exclusion Criteria

  • a.Subject with major illness like hepatitis, AIDS, malignancy and RA factor positive.
  • b.Subject with uncontrolled diabetes mellitus and hypertension, Koch’s arthritis, Septic arthritis, Chronic renal failure, Severe Systemic multi organ syndromes and uric acid cristal stones.
  • c.Subjects on opioids, anticoagulant drugs.
  • d.Classical contraindications for siravyadha procedure.

Outcomes

Primary Outcomes

Not specified

Similar Trials